|
Paranasal Sinus Neoplasms
|
C04.588.443.665.650.693 |
|
|
Oral Manifestations
|
C07.465.634 |
|
|
Hexosediphosphates
|
D09.894.417.592 |
|
|
Defamation
|
I01.198.240.240 |
|
|
Mucopolysaccharidosis VI
|
C16.320.565.595.600.670 |
|
|
Mucopolysaccharidoses
|
C16.320.565.595.600 |
|
|
Drug Trafficking
|
I01.198.240.247 |
|
|
Varenicline
|
D000068580 |
[A benzazepine derivative that functions as an ALPHA4-BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.
] |
|
Meningitis, Pneumococcal
|
C01.150.252.410.890.670.595 |
|
|
Ephedra
|
B01.650.940.800.575.156.577.222 |
|
|
Acid Sensing Ion Channels
|
D12.776.631.024 |
|
|
Tadalafil
|
D000068581 |
[A carboline derivative and PHOSPHODIESTERASE 5 INHIBITOR that is used primarily to treat ERECTILE DYSFUNCTION; BENIGN PROSTATIC HYPERPLASIA and PRIMARY PULMONARY HYPERTENSION.
] |
|
Certolizumab Pegol
|
D000068582 |
[A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
] |
|
Synephrine
|
D02.092.063.291.870 |
|
|
Trichothecenes, Type A
|
D02.455.849.765.850.950 |
|
|
Uridine Diphosphate Xylose
|
D03.383.742.686.850.600.677.800 |
|
|
Phosphatidylserines
|
D10.570.755.375.760.400.971 |
|
|
Citraconic Anhydrides
|
D03.383.312.250 |
|
|
United States Environmental Protection Agency
|
I01.409.418.750.937 |
|
|
Celecoxib
|
D000068579 |
[A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.
] |
